跳至主要内容
临床试验/CTRI/2019/07/020005
CTRI/2019/07/020005尚未招募4 期

A Prospective, open-label, post-marketing, observational, multi-center, comparative study for assessment of effectiveness and safety of ImmulinaTM-800 as add-on to Standard of Care in the Treatment and Prophylaxis of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) - IMSA

Wockhardt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Patients providing written informed consent.
  • 2.Patients aged 40-65 years (Both inclusive).
  • 3.Patient must be a diagnosed case of Chronic Obstructive Pulmonary Disease.

排除标准

  • 1.Those unable to provide written informed consent.
  • 2.Females who are pregnant
  • 3.Patients not willing to practice barrier contraception during the study period.
  • 4.Patients with known history of active tuberculosis, Acquired Immunodeficiency Disease or autoimmune disorder.
  • 5.Patients with known hypersensitivity to Pidotimod.

研究者

发起方
Wockhardt Ltd

相似试验